Pre-operative immunotherapy with tumor cryoablation (cryo) plus ipilimumab (ipi) induces potentially favorable systemic and intratumoral immune effects in early stage breast cancer (ESBC) patients
Crossref DOI link: https://doi.org/10.1186/2051-1426-3-S1-O6
Published Online: 2015-08-14
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Page, David B
Diab, Adi
Yuan, Jianda
Dong, Zhiwan
Soloman, Stephen B
Patil, Sujata
Hudis, Clifford A
Wolchok, Jedd D
Norton, Larry
McArthur, Heather L
Article History
First Online: 14 August 2015